124 related articles for article (PubMed ID: 38184433)
21. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
[TBL] [Abstract][Full Text] [Related]
22. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Wilms tumor treatment in western Kenya.
Uittenboogaard A; Njuguna F; Mostert S; Langat S; van de Velde ME; Olbara G; Vik TA; Kaspers GJL
Pediatr Blood Cancer; 2022 Apr; 69(4):e29503. PubMed ID: 34908225
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
[TBL] [Abstract][Full Text] [Related]
25. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
26. Nephron-sparing procedures in 11 patients with Wilms' tumor.
Linni K; Urban C; Lackner H; Höllwarth ME
Pediatr Surg Int; 2003 Aug; 19(6):457-62. PubMed ID: 12756594
[TBL] [Abstract][Full Text] [Related]
27. Adult Wilms tumour.
Zdrojowy R; Sawicz-Birkowska K; Apoznański W; Patkowski D; Szydełko T; Pietras W; Dembowski J
Int Urol Nephrol; 2011 Sep; 43(3):691-6. PubMed ID: 21110097
[TBL] [Abstract][Full Text] [Related]
28. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
[TBL] [Abstract][Full Text] [Related]
29. Late effects in children treated with radiation therapy for Wilms' tumor.
Paulino AC; Wen BC; Brown CK; Tannous R; Mayr NA; Zhen WK; Weidner GJ; Hussey DH
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1239-46. PubMed ID: 10725637
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of Wilms' tumor in eastern China: 10 years of experience at a single center.
Yao W; Li K; Xiao X; Gao J; Dong K; Xiao X; Lv Z
J Invest Surg; 2012 Jun; 25(3):181-5. PubMed ID: 22583015
[TBL] [Abstract][Full Text] [Related]
31. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
[TBL] [Abstract][Full Text] [Related]
32. Does nephroblastomatosis influence the natural history and relapse rate in Wilms' tumour? A single centre experience over 11 years.
Bergeron C; Iliescu C; Thiesse P; Bouvier R; Dijoud F; Ranchere-Vince D; Basset T; Chappuis JP; Buclon M; Frappaz D; Brunat-Mentigny M; Philip T
Eur J Cancer; 2001 Feb; 37(3):385-91. PubMed ID: 11239761
[TBL] [Abstract][Full Text] [Related]
33. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
Ora I; van Tinteren H; Bergeron C; de Kraker J;
Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
[TBL] [Abstract][Full Text] [Related]
34. [Wilms' tumour: A review of 15 years recent experience].
Illade L; Hernandez-Marques C; Cormenzana M; Lassaletta Á; Andión Catalán M; Ruano D; Fioravantti V; Madero López L
An Pediatr (Engl Ed); 2018 Mar; 88(3):140-149. PubMed ID: 28479004
[TBL] [Abstract][Full Text] [Related]
35. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of effect of preoperative chemotherapy on Wilms' tumor histopathology.
Taskinen S; Lohi J; Koskenvuo M; Taskinen M
J Pediatr Surg; 2018 Aug; 53(8):1611-1614. PubMed ID: 29074135
[TBL] [Abstract][Full Text] [Related]
37. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
[TBL] [Abstract][Full Text] [Related]
38. Risks and benefits of percutaneous biopsy and primary chemotherapy in advanced Wilms' tumour.
Dykes EH; Marwaha RK; Dicks-Mireaux C; Sams V; Risdon RA; Duffy PG; Ransley PG; Pritchard J
J Pediatr Surg; 1991 May; 26(5):610-2. PubMed ID: 1648128
[TBL] [Abstract][Full Text] [Related]
39. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.
Zekri W; Yacoub DM; Ibrahim A; Madney Y
J Egypt Natl Canc Inst; 2020 May; 32(1):21. PubMed ID: 32372372
[TBL] [Abstract][Full Text] [Related]
40. Wilms tumour treatment in Sudan: A 10-year single-centre experience.
Abdalla M; Hameed S
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1604. PubMed ID: 35142098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
